ARCHIVES

IOM: No Negligence In FIAU Clinical Trial That Killed Five

This article is from The Cancer Letter archive.

Vol. 21 No. 13 | March 31, 1995

Download PDF Visit The Full Archive

Related Articles

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

Celgene Signs CRADA With NCI For Development Of CDC-501.

June 30, 2000

Antidepressant Provides Cool Choice For Hot Flashes

February 22, 2002

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients

December 5, 1986

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010